Docosahexaenoic acid significantly reduces tumor cell growth in preclinical models of ovarian cancer
O. Bilyk, B. Hamedi, I. Dutta, M. Newell, A. B. Bukhari, A. M. Gamper, R. C. McVea, J. Liu, J. Schueler, G. M. Siegers, C. J. Field, L.-M. Postovit
This study shows that docosahexaenoic acid (DHA) enhances the anti-cancer effects of carboplatin in ovarian cancer models, reducing tumor growth and improving survival.
bioRxiv · Nov 10, 2020Cancer Biology